Genes & biomarkers
BRAF variants
BRAF · V600E / V600K
The BRAF variant and cancer type influence the treatment combination.
Sources checked · Introductory guide
On this page
What does this result mean?
BRAF transmits growth signals. Some variants, including V600E, can keep signaling active. Not all BRAF variants have the same behavior.[1]
How does it connect to treatment?
Combinations such as dabrafenib with trametinib are used in selected BRAF-altered melanomas and lung cancers. Colorectal cancer may need a different combination; regimens cannot simply be copied between cancers.[2]
What should I check in my report?
Distinguish V600E, V600K and non-V600 variants. Ask which combination has evidence for your cancer and whether treatment requires more than one drug.
Questions for your care team
- Which combination fits my BRAF variant and cancer type?
- Which treatments or trials fit my cancer type, stage and previous treatment?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- MedlinePlus Genetics · BRAF (opens in a new tab)
- NCI · Dabrafenib (opens in a new tab)
- NCI · Cetuximab (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.